Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record for the FG-3019 study is displayed, with details about the study’s purpose, participant criteria, treatment arms, locations, and measured outcomes.SummaryDifference39%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now renders a 403 Forbidden error page with a standard header and footer, replacing the previous study-content view. This indicates access is blocked rather than a deliberate update to the study information.SummaryDifference16%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.